Nucleome
Decoding the dark matter of the human genome to deliver first-in-class precision medicines
Nucleome has the unique ability to discover and validate first-in-class targets through genetics in the dark genome. Understanding the role of these genetic variants has been a long-standing challenge, hindering the translation of the human genome into useful drug discovery insights.
